Suzanne Clark, MFTI, MA | |
251 West Weber Canyon Road, Oakley, UT 84055-0357 | |
(435) 783-5001 | |
Not Available |
Full Name | Suzanne Clark |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 251 West Weber Canyon Road, Oakley, Utah |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1720262603 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | 6486848-3904 (Utah) | Primary |
Mailing Address | Practice Location Address |
---|---|
Suzanne Clark, MFTI, MA 251 West Weber Canyon Road, Oakley, UT 84055-0357 Ph: (435) 783-5001 | Suzanne Clark, MFTI, MA 251 West Weber Canyon Road, Oakley, UT 84055-0357 Ph: (435) 783-5001 |
News Archive
Vanderbilt University researchers have discovered that early visual areas, long believed to play no role in higher cognitive functions such as memory, retain information previously hidden from brain studies.
A University of Alabama at Birmingham study released today reports that ovarian cancer screenings do not reduce a woman's risk of death from the disease and the invasive medical procedures may create associated health problems.
A technique for producing natural killer T (NKT) cells, known for their role in suppressing tumor growth, has been successfully demonstrated for the first time using induced pluripotent stem (iPS) cells. Developed by researchers at RIKEN, Japan's flagship research institution, the technique opens the door to effective new cell-targeted treatments for cancer.
With gold nanoparticles, DNA and some smart chemistry as their tools, scientists at Northwestern University have developed a simple "litmus test" for mercury that eventually could be used for on-the-spot environmental monitoring of bodies of water, such as rivers, streams, lakes and oceans, to evaluate their safety as food and drinking water sources.
Emerging Healthcare Solutions, Inc. announced today that its affiliate, Celulas Genetica, purchased a license to develop and market a revolutionary new medical treatment known as the Rutherford Procedure.
› Verified 8 days ago